Union Rasagiline Tablet 1 mg (Rasagiline Mesylate)

Adult dose

This drug is administered orally to adults once daily as monotherapy or adjunctive therapy. 1) Monotherapy or adjunctive therapy with a dopamine agonist: Administer 1mg orally once daily. 2) Adjunctive therapy with levodopa: The recommended initial dose for patients taking levodopa is 0.5mg once daily. If well tolerated and an adequate clinical response is not achieved, the dose may be increased to 1mg once daily. This drug may be taken with or without food.

This medication should not be administered to certain patients. Firstly, individuals who are allergic to the active ingredient or other components should not take this drug. Secondly, those who are currently taking other MAO inhibitors or have stopped taking them for less than two weeks should avoid this medication. Thirdly, patients currently using or who have stopped taking a medication called pethidine within the last two weeks should not use this drug. Fourthly, patients currently using medications like tramadol or dextromethorphan should not take this medication. Fifthly, patients with moderate or severe liver impairment should not take this drug. The use of this medication may result in various side effects. The most common side effects include headache, flu-like symptoms, dermatitis, dizziness, muscle pain, joint pain, nausea, and insomnia. Additionally, symptoms such as depression, hallucinations, conjunctivitis, angina, rhinitis, fever, and fatigue can also occur. Occasionally, serious side effects such as myocardial infarction or cerebrovascular accidents have been reported, and abnormalities in blood or allergic reactions may occur. Dose adjustment is required for patients with liver impairment and this medication should not be given to patients with severe hepatic dysfunction. No special dosage adjustments are usually needed for patients with mild renal impairment. Patients should exercise caution when driving or operating dangerous machinery while taking this medication. Drowsiness or sudden sleepiness can occur; thus, patients should avoid driving or operating machinery if these symptoms arise. Caution is advised when taking this medication alongside other drugs, especially with other MAO inhibitors, pethidine, tramadol, dextromethorphan, some antidepressants, and sympathomimetics, as serious side effects can occur; consultation with a physician or pharmacist is essential. Women who are pregnant or breastfeeding should be cautious when taking this medication and consult with professionals as it may interfere with lactation. Safety and efficacy in children under the age of 18 have not been established, so it is advisable to avoid using this medication in that age group. In cases of overdose, serious symptoms such as hypertensive crisis, serotonin syndrome, and hypomania can occur; therefore, immediate medical attention is required. No specific antidote for overdose exists, so appropriate treatment should be provided based on symptoms. This medication should be stored at temperatures between 1°C and 25°C, in a place out of reach of children. Additionally, transferring to another container should be avoided as it may compromise the quality.

• Influenza
• skin cancer
• leukopenia
• allergy
• loss of appetite
• depression
• hallucinations
• headache
• cerebrovascular accident
• conjunctivitis

This medication should be stored in a sealed container to prevent exposure to air or moisture, and should be kept in a cool place between 1°C and 25°C. Proper storage will maintain the efficacy of the drug and ensure safe usage.

Appearance

White round tablets

Package unit

30 tablets/bottle